These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7033154)

  • 1. Inorganic tin: chemistry, disposition and role in nuclear medicine diagnostic skeletal imaging agents.
    Francis MD; Tofe AJ; Hiles RA; Birch CG; Bevan JA; Grabenstetter RJ
    Int J Nucl Med Biol; 1981; 8(2-3):145-52. PubMed ID: 7033154
    [No Abstract]   [Full Text] [Related]  

  • 2. Gentisic acid: a new stabilizer for low tin skeletal imaging agents: concise communication.
    Tofe AJ; Bevan JA; Fawzi MB; Francis MD; Silberstein EB; Alexander GA; Gunderson DE; Blair K
    J Nucl Med; 1980 Apr; 21(4):366-70. PubMed ID: 7381564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone-seeking radionuclides: an in vivo study of factors affecting skeletal uptake.
    Genant HK; Bautovich GJ; Singh M; Lathrop KA; Harper PV
    Radiology; 1974 Nov; 113(2):373-82. PubMed ID: 4417457
    [No Abstract]   [Full Text] [Related]  

  • 4. 99mTc bone scanning agents--IV. Chemical characterization of 99mTc(Sn)-pyrophosphate complexes.
    Kroesbergen J; Roozen AM; Gelsema WJ; de Ligny CL
    Int J Rad Appl Instrum B; 1988; 15(2):209-14. PubMed ID: 3366621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanisms of phosphate radionuclide accumulation in a myocardial infarct focus].
    Shepeleva II; Rossel's AN
    Med Radiol (Mosk); 1979 Jan; 24(1):66-9. PubMed ID: 215866
    [No Abstract]   [Full Text] [Related]  

  • 6. 99mTc bone scanning agents--II. Adsorption of 99mTc(Sn)pyrophosphate complexes on the mineral phase of bone.
    Kroesbergen J; van Steijn AM; Gelsema WJ; de Ligny CL
    Int J Nucl Med Biol; 1986; 12(6):411-7. PubMed ID: 3011692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The chemistry of rhenium and technetium as related to the use of isotopes of these elements in therapeutic and diagnostic nuclear medicine.
    Deutsch E; Libson K; Vanderheyden JL; Ketring AR; Maxon HR
    Int J Rad Appl Instrum B; 1986; 13(4):465-77. PubMed ID: 3793504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Centralized radiopharmaceutical services of the Indiana University Medical Center.
    Kavula MP
    Am J Hosp Pharm; 1974 Feb; 31(2):158-64. PubMed ID: 4815849
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemistry of technetium 99m.
    Steigman J; Richards P
    Semin Nucl Med; 1974 Jul; 4(3):269-79. PubMed ID: 4366840
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of iron-dextran on the biodistribution of technetium pyrophosphate.
    Choy D; Maddalena DJ; Murray IP
    Int J Nucl Med Biol; 1982; 9(4):277-82. PubMed ID: 7186499
    [No Abstract]   [Full Text] [Related]  

  • 11. [A comparative radioisotope study of calcium metabolism in bone and teeth of rats (author's transl)].
    Kutzner J; Sachs A; Grimm W
    Nuklearmedizin; 1978 Apr; 17(2):63-5. PubMed ID: 662702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 99Tcm complexes for skeletal scintigraphy. Physico-chemical factors affecting bone and bone-marrow uptake.
    Cox PH
    Br J Radiol; 1974 Dec; 47(564):845-50. PubMed ID: 4434054
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of Fe(II) or Sn(II) alone for technetium labeling of albumin.
    Lin MS; Winchell HS; Shipley BA
    J Nucl Med; 1971 May; 12(5):204-11. PubMed ID: 5580834
    [No Abstract]   [Full Text] [Related]  

  • 14. [Possibilities and limits of bone scintigraphy].
    Börner W
    Z Orthop Ihre Grenzgeb; 1978 Aug; 116(4):489-93. PubMed ID: 706593
    [No Abstract]   [Full Text] [Related]  

  • 15. Oxidation state of technetium in bone scanning agents as determined at carrier concentration by amperometric titration.
    Russell CD; Cash AG
    Int J Appl Radiat Isot; 1979 Aug; 30(8):485-8. PubMed ID: 225280
    [No Abstract]   [Full Text] [Related]  

  • 16. Time-dependent characteristics of Sn-complexes for preparing 99mTc-labelled radiopharmaceuticals and their bioavailabilities--a review.
    Noronha OP
    Nuklearmedizin; 1978 Jul; 17(3):110-25. PubMed ID: 704364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tin-117m: production, chemistry and evaluation as a bone-scanning agent.
    Yano Y; Chu P; Anger HO
    Int J Appl Radiat Isot; 1973 Jun; 24(6):319-25. PubMed ID: 4198816
    [No Abstract]   [Full Text] [Related]  

  • 18. An historical survey of bone scanning.
    Ram PC; Fordham EW
    Semin Nucl Med; 1979 Jul; 9(3):190-6. PubMed ID: 388629
    [No Abstract]   [Full Text] [Related]  

  • 19. 99m Tc-labelled chelates for nuclear medicine application. Radiopharmacy without knowledge of chemical structure?
    Nakken KF
    J Oslo City Hosp; 1984 Jun; 34(6):49-60. PubMed ID: 6088742
    [No Abstract]   [Full Text] [Related]  

  • 20. Altered 99mTc-pertechnetate distribution in a thyroid scan after 99mTc-Sn pyrophosphate administration.
    Montelibano EB; Ford DR; Sayle BA
    Clin Nucl Med; 1979 Jul; 4(7):277-82. PubMed ID: 223800
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.